The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) to detect neuroendocrine prostate cancer genomic and DNA methylation changes.
 
Himisha Beltran
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Genzyme; GlaxoSmithKline; Janssen Oncology
Research Funding - Abbvie/Stemcentrx (Inst); Janssen (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Alessandro Romanel
No Relationships to Disclose
 
Vincenza Conteduca
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; Sanofi/Aventis
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen-Cilag; Sanofi/Aventis
 
Nicola Casiraghi
No Relationships to Disclose
 
Michael Sigouros
No Relationships to Disclose
 
Gian Marco Franceschini
No Relationships to Disclose
 
Tarcisio Fedrizzi
No Relationships to Disclose
 
sheng-Yu Ku
No Relationships to Disclose
 
Alicia Alonso
No Relationships to Disclose
 
Juan Miguel Mosquera
Research Funding - Personal Genome Diagnostics
Travel, Accommodations, Expenses - Personal Genome Diagnostics
 
Emma Dann
No Relationships to Disclose
 
Andrea Sboner
No Relationships to Disclose
 
Jenny Xiang
No Relationships to Disclose
 
Olivier Elemento
Stock and Other Ownership Interests - OneThree Biotech; Owkin; Volastra Therapeutics
 
David M. Nanus
Consulting or Advisory Role - Roche/Genentech
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Zenith Epigenetics (Inst)
 
Scott T. Tagawa
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Clovis Oncology; Dendreon; Endocyte; Genentech; Immunomedics; Janssen; Karyopharm Therapeutics; Medivation; Pfizer; QED Therapeutics; Sanofi; Tolmar
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Travel, Accommodations, Expenses - Amgen; Immunomedics; Sanofi
 
Matteo Benelli
No Relationships to Disclose
 
Francesca Demichelis
Patents, Royalties, Other Intellectual Property - Co-inventor on a patent filed by The University of Michigan and The Brigham and Women’s Hospital covering the diagnostic and therapeutic fields for ETS fusions in prostate cancer. The diagnostic field has been licensed to Gen-Probe.